Brady vs Daktronics
BRC and DAKT side by side, both in miscellaneous manufacturing industries. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BRC and DAKT compare
Brady is the larger company, worth 4.0 times as much as Daktronics ($3.9B against $958M).
On earnings, Brady is cheaper: it trades at 19.1× trailing earnings, against 20.3× for Daktronics.
Daktronics grew revenue faster over the last twelve months (14.0% versus 9.8% for Brady).
Brady keeps more of each dollar of sales as profit, with a net margin of 12.4% compared with 5.7% at Daktronics.
Brady pays a dividend yielding 1.2%; Daktronics does not pay one.
Daktronics scores higher on the StockData Score (14 against 13 for Brady), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BRC | DAKT |
|---|---|---|
| Size and price | ||
| Market cap | $3.9B | $958M |
| Share price | $82.40 | $19.91 |
| Change, 1 year | 8.8% | 4.2% |
| Change, 5 years | 63.8% | 299% |
| Beta (5Y) | 0.66 | 1.18 |
| Employees | 6,325 | 2,423 |
| StockData Score | ||
| Total score | 13 | 14 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 2 | 4 (better) |
| Performance score | 5 | 5 |
| Health score | 3 | 4 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 19.1× (better) | 20.3× |
| P/S | 2.3× | 1.1× (better) |
| P/B | 2.8× (better) | 3.0× |
| EV/EBITDA | 11.9× | 10.0× (better) |
| P/FCF | 20.1× (better) | 24.1× |
| PEG | – | 0.24 |
| FCF yield | 5.0% (better) | 4.2% |
| Fair value | $72.47 | $19.09 |
| Margin of safety | −13.7% | −4.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 9.8% | 14.0% (better) |
| Revenue growth, 5Y average | 7.7% | 11.7% (better) |
| Net income growth (TTM) | 8.5% | 328% (better) |
| EPS growth (TTM) | 9.7% | – |
| EPS growth, 5Y average | – | 30.8% |
| Profitability | ||
| Gross margin | 51.7% (better) | 27.6% |
| Operating margin | 15.9% (better) | 7.3% |
| Net margin | 12.4% (better) | 5.7% |
| FCF margin | 11.6% (better) | 4.7% |
| Return on equity | 16.1% | 16.2% (better) |
| Return on invested capital | 19.1% | 29.8% (better) |
| Financial health | ||
| Debt / equity | – | 0.03 |
| Net debt / EBITDA | – | −1.76 |
| Interest coverage | 27.2× | – |
| Current ratio | 1.94 | 2.17 (better) |
| Altman Z-score | 7.39 (better) | 4.71 |
| Piotroski F-score | 7 | 8 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.2% | – |
| Payout ratio | 22.5% | – |
| Buyback yield | 1.1% | 2.0% (better) |
| Shareholder yield | 2.3% (better) | 2.0% |
| Ownership | ||
| Held by institutions | 79.5% | 76.1% |
| Held by insiders | 3.2% | 27.2% |
| Insider net buying, 12 months | −$695K | −$145K (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 2.9% | 6.6% |
Go deeper
- BRC stock overview
- BRC income statement
- BRC valuation and score
- DAKT stock overview
- DAKT income statement
- DAKT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.